In HAE patients, C1-INH deficiency affects KKS control, resulting in the development of kallikrein activity in the plasma and the subsequent release of bradykinin (BK), the predominant mediator of enhanced vascular permeability in angioedema attacks. The gene discussed is KLK4; the disease is hereditary angioedema.